Detailed Information on Publication Record
2021
Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology
ZEYMERT, U., P. LUDMAN, N. DANCHIN, Petr KALA, C. LAROCHE et. al.Basic information
Original name
Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology
Authors
ZEYMERT, U. (guarantor), P. LUDMAN, N. DANCHIN, Petr KALA (203 Czech Republic, belonging to the institution), C. LAROCHE, M. SADEGHI, R. CAPORALE, S. M. SHAHEEN, J. LEGUTKO, Z. IAKOBSISHVILI, K. F. ALHABIB, Z. MOTOVSKA, M. STUDENCAN, J. MIMOSO, D. BECKER, D. ALEXOPOULOS, Z. KERESESELIDZE, S. STOJKOVIC, P. ZELVEIAN, A. GODA, E. MIRRAKHIMOV, G. BAJRAKTARI, H. AL-FARHAN, P. SERPYTIS, B. RAUNGAARD, T. MARANDI, A. M. MOORE, M. QUINN, P. P. KARJALAINEN, G. TATU-CHITOLU, C. P. GALE, A. P. MAGGIONI and F. WEIDINGER
Edition
European heart journal, Oxford, Oxford University Press, 2021, 0195-668X
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30201 Cardiac and Cardiovascular systems
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 35.855
RIV identification code
RIV/00216224:14110/21:00124152
Organization unit
Faculty of Medicine
UT WoS
000738992000010
Keywords in English
ST-elevation myocardial infarction; Primary percutaneous coronary intervention; Observational studies; Reperfusion therapy
Tags
International impact, Reviewed
Změněno: 17/5/2022 13:11, Mgr. Tereza Miškechová
Abstract
V originále
Aims The aim of this study was to determine the contemporary use of reperfusion therapy in the European Society of Cardiology (ESC) member and affiliated countries and adherence to ESC clinical practice guidelines in patients with ST-elevation myocardial infarction (STEMI). Methods and results Prospective cohort (EURObservational Research Programme STEMI Registry) of hospitalized STEMI patients with symptom onset <24h in 196 centres across 29 countries. A total of 11 462 patients were enrolled, for whom primary percutaneous coronary intervention (PCI) (total cohort frequency: 72.2%, country frequency range 0-100%), fibrinolysis (18.8%; 0-100%), and no reperfusion therapy (9.0%; 0-75%) were performed. Corresponding in-hospital mortality rates from any cause were 3.1%, 4.4%, and 14.1% and overall mortality was 4.4% (country range 2.55.9%). Achievement of quality indicators for reperfusion was reported for 92.7% (region range 84.8 97.5%) for the performance of reperfusion therapy of all patients with STEMI <12h and 54.4% (region range 37.1-70.1%) for timely reperfusion. Conclusions The use of reperfusion therapy for STEMI in the ESC member and affiliated countries was high. Primary PCI was the most frequently used treatment and associated total in-hospital mortality was below 5%. However, there was geographic variation in the use of primary PCI, which was associated with differences in in-hospital mortality. [GRAPHICS] .